Institute De Cancerologie De L'Ouest Site Paul Papin Oncologie Medicale

Saint-Herblain 44805

0 studies enrolling now · 1 studies all time

What they study most

KRAS Activating Mutation, Non Small Cell Lung Cancer

Studies at this site

• A Study of Avutometinib (VS-6766) + Defactinib in Recurrent KRAS G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer — Completed